As of 2020, the National Average Drug Acquisition Cost (NADAC) in the United States for Avonex was $6,872.94 for a 30 mcg kit.Avonex and Rebif are on the top ten best-selling multiple sclerosis drugs of 2013:It is an example of a specialty drug that would only be available through a specialty pharmacy. This is because it requires a refrigerated chain of distribution and costs $17,000-a-year. Research
COVID-19
Interferon beta-1a administered subcutaneously or intravenously was investigated since March 2020 as a potential treatment in patients hospitalized with COVID-19 in a multinational Solidarity trial (initially in combination with lopinavir) but it did not reduce in-hospital mortality compared to local standard of care.SNG001, an inhalation formulation of interferon beta-1a, is being developed as a treatment for COVID-19 by Synairgen. A pilot trial in hospitalized patients showed higher odds of clinical improvement with SNG001 compared to placebo and in January 2021 a phase 3 trial in this population started. References
External links
"Interferon beta-1a". Drug Information Portal. U.S. National Library of Medicine. "Interferon Beta-1a Intramuscular Injection". MedlinePlus.
Drug Information Portal. U.S. National Library of Medicine. "Relebactam". Drug Information Portal. U.S. National Library of Medicine.